Array BioPharma Investigative Site

Bellinzona 6500

0 studies enrolling now · 1 studies all time

What they study most

AML, Advanced and Selected Solid Tumors, High Risk and Very High Risk MDS

Studies at this site

• A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors — Completed